Abstract: An example network analysis system includes a memory storing telemetry data received from a plurality of network devices, the plurality of network devices includes extract entity information and connectivity information from the received telemetry data, wherein the entity information represents one or more network devices of the plurality of network devices and the connectivity information represents network connections between one or more devices of the plurality of network devices; and store the connectivity information and entity information as a network topology graph in a graph database, wherein the entity information is stored as nodes of the network topology graph and the connectivity information is stored as edges of network topology graph, and wherein the network topology graph represents an organization level topology of the organization network.

Abstract: A system for generating an advanced surround view for a vehicle includes a plurality of cameras to generate image data. Sensors are configured to determine kinematic data of the vehicle. Kinematic data are also obtained by a visual odometry module and/or a deep-vision mechanism. A processor is configured to process image data captured by the plurality of cameras to generate a 360-degree surround view layer representative of a surrounding area. The processor is further configured to construct an improved bicycle kinematic model for processing kinematic data to generate an under-chassis layer representative of an area under the vehicle. The processor is further configured to generate a 3D vehicle model layer and overlay objects layer. Display screens display a GUI of combined scene of the 360-degree surround view layer, under-chassis layer, 3D vehicle model layer and overlay objects layer as would be viewed from a virtual camera viewpoint.

Abstract: An example network analysis system includes a memory storing telemetry data received from a plurality of network devices, the plurality of network devices includes extract entity information and connectivity information from the received telemetry data, wherein the entity information represents one or more network devices of the plurality of network devices and the connectivity information represents network connections between one or more devices of the plurality of network devices; and store the connectivity information and entity information as a network topology graph in a graph database, wherein the entity information is stored as nodes of the network topology graph and the connectivity information is stored as edges of network topology graph, and wherein the network topology graph represents an organization level topology of the organization network.

Abstract: An example network analysis system includes a memory storing telemetry data received from a plurality of network devices, the plurality of network devices includes extract entity information and connectivity information from the received telemetry data, wherein the entity information represents one or more network devices of the plurality of network devices and the connectivity information represents network connections between one or more devices of the plurality of network devices; and store the connectivity information and entity information as a network topology graph in a graph database, wherein the entity information is stored as nodes of the network topology graph and the connectivity information is stored as edges of network topology graph, and wherein the network topology graph represents an organization level topology of the organization network.

Abstract: The method of synchronizing data frames between 5G baseband processing stations by a global position system (GPS)-integrated local oscillator block control, including the following steps: step 1: synchronize the baseband processor's local oscillator block with the GPS's 1 pps (pulse per second) pulse and generate a 10 ms (millisecond) pulse from the local oscillator; step 2: use the 10 ms synchronous pulse sync monitor block to get the sync offset between this pulse and the GPS 1 pps pulse; step 3: use the control algorithm to reconfigure the local oscillator so that the 10 ms synchronous pulse can follow the 1 pps GPS pulse.

Abstract: A traction tower trap assembly with straps and finger traps that are easily adjustable and releasable. The traction tower assembly includes straps for parts of the arm, such as the patient's bicep or forearm, and finger traps to traction parts of the arm and fingers for surgical procedures. The forearm traction tower assembly includes a tower having first and second sides. The tower is connected to a base plate with a first and second slots extending partially therethrough. The assembly includes a strap made of a length of material attached to first and second adjustment mechanisms. The first adjustment mechanism is slidable within the first slot of the base plate and the second adjustment mechanism is slidable within the second slot of the base plate.

Abstract: A knot pusher for quickly loading suture without needing to thread a distal end. The knot pusher includes an actuator housing having an actuator moveable between an open position and a closed position and an elongated tube extending from the actuator housing. The knot pusher includes at least two slots, a gate slot extending through the elongated tube and a suture loading slot extending through the elongated tube and traversing the gate slot. A moveable gate cross bar is connected to the actuator such that the gate cross bar moves with the actuator between the open position and the closed position. When the actuator is in the closed position, the gate cross bar extends through at least a portion of the suture loading slot. The knot pusher may also include an ergonomic loop handle that enforces the correct orientation of the knot pusher for use.

Abstract: The method of synchronizing data frames between 5G baseband processing stations by GPS-integrated local oscillator block control, including the following steps: step 1: synchronize the baseband processor's local oscillator block with the GPS's 1 pps pulse and generate a 10 ms pulse from the local oscillator; step 2: use the 10 ms synchronous pulse sync monitor block to get the sync offset between this pulse and the GPS 1 pps pulse; step 3: use the control algorithm to reconfigure the local oscillator so that the 10 ms synchronous pulse can follow the 1 pps GPS pulse.

Abstract: A traction tower assembly and traction tower scale. The traction tower assembly includes a tower assembly including a first tower having a first side surface and a second tower having a second side surface positioned adjacent to the first side surface, wherein the second tower is movable with respect to the first tower in a first direction and in a second direction; and an elongated arm assembly attached to and extending from the tower assembly.

Abstract: The present invention is directed to substituted propylamine derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.

Abstract: The present invention is directed to arylamino-arylpropanolamine derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.

Abstract: The present invention is directed to aryl sulfamide derivatives of formula I: or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders.

Abstract: The present invention is directed to phenylaminopropanol derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.

Abstract: This invention provides estrogen receptor modulators of formula I, having the structure wherein, R1, R2, R3, R4, R5, and R6 are as defined in the specification, or a N-oxide thereof or a pharmaceutically acceptable salt thereof or a prodrug thereof.

Abstract: The present invention is directed to benzothiadiazolylphenylalkylamine derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.

Abstract: The present invention is directed to aryl sulfamide derivatives of formula I: or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders.

Abstract: The present invention is directed to substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.

Abstract: The present invention is directed to phenylpiperazine cycloalkanol derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.

Abstract: The present invention is directed to phenylaminopropanol derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.

Abstract: The present invention is directed to phenylaminopropanol derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.